Viewing Study NCT00584961


Ignite Creation Date: 2025-12-24 @ 12:14 PM
Ignite Modification Date: 2025-12-27 @ 9:10 PM
Study NCT ID: NCT00584961
Status: COMPLETED
Last Update Posted: 2021-02-21
First Post: 2007-12-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-05
Start Date Type: None
Primary Completion Date: 2009-02
Primary Completion Date Type: ACTUAL
Completion Date: 2009-02
Completion Date Type: ACTUAL
First Submit Date: 2007-12-21
First Submit QC Date: None
Study First Post Date: 2008-01-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-02-18
Last Update Post Date: 2021-02-21
Last Update Post Date Type: ACTUAL